208 related articles for article (PubMed ID: 18407511)
1. Organ preservation strategies after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a multicenter retrospective cohort study.
Hui B; Wang X; Wang X; Qiao B; Duan J; Shang R; Yang W; Wang J; Chen K; Yang F; Jiang T; Lei J
Int J Surg; 2023 Aug; 109(8):2286-2292. PubMed ID: 37161431
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004).
Liu SY; Chen Q; Zhou C; Zhang H; Li W; Chen J; Hu J; Wu L; Chen Q; Dai Q; Shan JZ; Xu F; Liu SM; Wu YL
Cancer Immunol Immunother; 2023 Jul; 72(7):2257-2265. PubMed ID: 36871274
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancer.
Lengel HB; Zheng J; Tan KS; Liu CC; Park BJ; Rocco G; Adusumilli PS; Molena D; Yu HA; Riely GJ; Bains MS; Rusch VW; Kris MG; Chaft JE; Li BT; Isbell JM; Jones DR
J Thorac Cardiovasc Surg; 2023 May; 165(5):1682-1693.e3. PubMed ID: 36528430
[TBL] [Abstract][Full Text] [Related]
4. [Sleeve Resection for Right Upper Lobe Non-small Cell Lung Cancer After Systemic Chemotherapy and Immune Checkpoint Inhibitor Administration].
Hashimoto M; Masumoto T; Yoden M; Kaku R; Sawai S; Suzumura Y
Kyobu Geka; 2023 Dec; 76(13):1110-1114. PubMed ID: 38088077
[TBL] [Abstract][Full Text] [Related]
5. Pathologic Response Evaluation in Neoadjuvant-Treated Lung Cancer.
Dacic S
Surg Pathol Clin; 2024 Jun; 17(2):287-293. PubMed ID: 38692811
[TBL] [Abstract][Full Text] [Related]
6. Lung Cancer resection in the absence of pre-operative histology: The Accuracy of Multidisciplinary Team Consensus.
Whooley J; Weedle R; Breen D; Soo A
Eur J Surg Oncol; 2023 Sep; 49(9):106907. PubMed ID: 37080864
[TBL] [Abstract][Full Text] [Related]
7. Association of Heart Base Dose With Overall Survival in Patients With NSCLC Undergoing Postoperative Radiotherapy.
Ma Z; Yang X; Hui Z
J Thorac Oncol; 2023 Jun; 18(6):e62-e64. PubMed ID: 37210185
[No Abstract] [Full Text] [Related]
8. Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
Weissferdt A; Leung CH; Lin H; Sepesi B; William WN; Swisher SG; Cascone T; Lee JJ; Pataer A
Mod Pathol; 2024 Jan; 37(1):100353. PubMed ID: 37844869
[TBL] [Abstract][Full Text] [Related]
9. Total or partial vertebrectomy for lung cancer invading the spine.
Oka S; Matsumiya H; Shinohara S; Kuwata T; Takenaka M; Chikaishi Y; Hirai A; Imanishi N; Kuroda K; Yamada S; Uramoto H; Nakamura E; Tanaka F
Ann Med Surg (Lond); 2016 Dec; 12():1-4. PubMed ID: 27790371
[TBL] [Abstract][Full Text] [Related]
10. Advances of clinically approved small-molecule drugs for the treatment of non-small cell lung cancer.
Niu ZX; Wang YT; Lu N; Sun JF; Nie P; Herdewijn P
Eur J Med Chem; 2023 Dec; 261():115868. PubMed ID: 37844346
[TBL] [Abstract][Full Text] [Related]
11. Scapular dislocation following radical surgical excision of lung sarcomatoid carcinoma: A rare case report.
Wu Q; Qiao K; Liu J; Zhen S; Zhou Z
Medicine (Baltimore); 2024 Jan; 103(2):e36884. PubMed ID: 38215121
[TBL] [Abstract][Full Text] [Related]
12. Almonertinib as a neoadjuvant therapy for patients with a superior pulmonary sulcus tumor with activated EGFR mutation: A case report.
Kang K; Jiang Z; Kai J; Chen S; Xiong F
Exp Ther Med; 2023 Dec; 26(6):564. PubMed ID: 37954117
[TBL] [Abstract][Full Text] [Related]
13. Unresectable Stage III NSCLC Should Not be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection.
Moghanaki D; Lisberg A; Oh S; Lee JM
J Thorac Oncol; 2023 Sep; 18(9):1129-1133. PubMed ID: 37599046
[No Abstract] [Full Text] [Related]
14. Induction therapy for non-small cell lung cancer.
Cooper A; Chaft JE; Bott MJ
J Thorac Cardiovasc Surg; 2024 Feb; ():. PubMed ID: 38354767
[No Abstract] [Full Text] [Related]
15. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
Fischer S; Darling G; Pierre AF; Sun A; Leighl N; Waddell TK; Keshavjee S; de Perrot M
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1129-34. PubMed ID: 18407511
[TBL] [Abstract][Full Text] [Related]
16. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
18. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
